PYC Therapeutics Limited (PYC.AX)
AUD 1.0
(2.04%)
AUD 1.0
(2.04%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 60.91 Million AUD | 59.13% |
| 2023 | 38.28 Million AUD | 30.35% |
| 2022 | 29.36 Million AUD | 38.46% |
| 2021 | 21.21 Million AUD | 131.69% |
| 2020 | 9.15 Million AUD | 31.32% |
| 2019 | 6.97 Million AUD | -28.03% |
| 2018 | 9.68 Million AUD | 313.56% |
| 2017 | 2.34 Million AUD | -59.81% |
| 2016 | 5.82 Million AUD | 155.21% |
| 2015 | 2.28 Million AUD | 1.24% |
| 2014 | 2.25 Million AUD | -63.04% |
| 2013 | 6.1 Million AUD | 2.01% |
| 2012 | 5.98 Million AUD | -1.51% |
| 2011 | 6.07 Million AUD | 15.5% |
| 2010 | 5.26 Million AUD | 5.69% |
| 2009 | 4.97 Million AUD | -12.13% |
| 2008 | 5.66 Million AUD | 20.56% |
| 2007 | 4.69 Million AUD | 19.27% |
| 2006 | 3.93 Million AUD | 119.66% |
| 2005 | 1.79 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 59.35 Million AUD | 55.05% |
| 2024 Q2 | 24 Million AUD | 0.0% |
| 2024 Q4 | 36.57 Million AUD | 0.0% |
| 2023 Q4 | 18.72 Million AUD | 0.0% |
| 2023 FY | 38.28 Million AUD | 30.35% |
| 2023 Q2 | 19.95 Million AUD | 0.0% |
| 2022 FY | 29.36 Million AUD | 38.46% |
| 2022 Q4 | 17.34 Million AUD | 0.0% |
| 2022 Q2 | 12.14 Million AUD | 0.0% |
| 2021 FY | 21.21 Million AUD | 131.69% |
| 2021 Q2 | 7.55 Million AUD | 0.0% |
| 2021 Q4 | 10.58 Million AUD | 0.0% |
| 2020 Q4 | 4.79 Million AUD | 0.0% |
| 2020 FY | 9.15 Million AUD | 31.32% |
| 2020 Q2 | 4.36 Million AUD | 0.0% |
| 2019 Q4 | 3.11 Million AUD | 0.0% |
| 2019 FY | 6.97 Million AUD | -28.03% |
| 2019 Q2 | 1.05 Million AUD | 0.0% |
| 2018 Q2 | 2.87 Million AUD | 0.0% |
| 2018 FY | 9.68 Million AUD | 313.56% |
| 2018 Q4 | 73.89 Thousand AUD | 0.0% |
| 2017 Q4 | 1.3 Million AUD | 0.0% |
| 2017 FY | 2.34 Million AUD | -59.81% |
| 2017 Q2 | 1.04 Million AUD | 0.0% |
| 2016 Q2 | 1 Million AUD | 0.0% |
| 2016 FY | 5.82 Million AUD | 155.21% |
| 2016 Q4 | 813.78 Thousand AUD | 0.0% |
| 2015 Q2 | 1.11 Million AUD | 0.0% |
| 2015 FY | 2.28 Million AUD | 1.24% |
| 2015 Q4 | 1.17 Million AUD | 0.0% |
| 2014 Q2 | 1.21 Million AUD | 0.0% |
| 2014 Q4 | 1.04 Million AUD | 0.0% |
| 2014 FY | 2.25 Million AUD | -63.04% |
| 2013 Q3 | 1.07 Million AUD | -32.99% |
| 2013 Q2 | 1.59 Million AUD | 45.17% |
| 2013 Q1 | 1.1 Million AUD | 0.0% |
| 2013 FY | 6.1 Million AUD | 2.01% |
| 2013 Q4 | 1.24 Million AUD | 15.96% |
| 2012 Q4 | 1.1 Million AUD | 0.0% |
| 2012 Q2 | 1.1 Million AUD | 0.14% |
| 2012 Q3 | 1.1 Million AUD | 0.0% |
| 2012 FY | 5.98 Million AUD | -1.51% |
| 2012 Q1 | 1.09 Million AUD | 0.0% |
| 2011 FY | 6.07 Million AUD | 15.5% |
| 2011 Q2 | 1.09 Million AUD | 14.71% |
| 2011 Q3 | 1.09 Million AUD | 0.0% |
| 2011 Q4 | 1.09 Million AUD | 0.0% |
| 2011 Q1 | 957.61 Thousand AUD | 0.0% |
| 2010 Q1 | 879.02 Thousand AUD | 0.0% |
| 2010 FY | 5.26 Million AUD | 5.69% |
| 2010 Q4 | 957.61 Thousand AUD | 0.0% |
| 2010 Q2 | 957.61 Thousand AUD | 8.94% |
| 2010 Q3 | 957.61 Thousand AUD | 0.0% |
| 2009 Q1 | 327.07 Thousand AUD | 0.0% |
| 2009 Q2 | 879.02 Thousand AUD | 168.75% |
| 2009 Q3 | 879.02 Thousand AUD | 0.0% |
| 2009 FY | 4.97 Million AUD | -12.13% |
| 2009 Q4 | 879.02 Thousand AUD | 0.0% |
| 2008 Q4 | 327.07 Thousand AUD | 0.0% |
| 2008 FY | 5.66 Million AUD | 20.56% |
| 2008 Q1 | 690.59 Thousand AUD | 0.0% |
| 2008 Q2 | 327.07 Thousand AUD | -52.64% |
| 2008 Q3 | 327.07 Thousand AUD | 0.0% |
| 2007 Q3 | 690.59 Thousand AUD | 0.0% |
| 2007 FY | 4.69 Million AUD | 19.27% |
| 2007 Q4 | 690.59 Thousand AUD | 0.0% |
| 2007 Q2 | 690.59 Thousand AUD | 201.14% |
| 2007 Q1 | 229.33 Thousand AUD | 0.0% |
| 2006 Q4 | 229.33 Thousand AUD | 0.0% |
| 2006 Q2 | 229.33 Thousand AUD | 977.78% |
| 2006 Q3 | 229.33 Thousand AUD | 0.0% |
| 2006 FY | 3.93 Million AUD | 119.66% |
| 2006 Q1 | 21.27 Thousand AUD | 0.0% |
| 2005 Q3 | 21.27 Thousand AUD | 0.0% |
| 2005 Q2 | 21.27 Thousand AUD | 0.0% |
| 2005 FY | 1.79 Million AUD | 0.0% |
| 2005 Q4 | 21.27 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AdAlta Limited | 6.76 Million AUD | -799.867% |
| Biome Australia Limited | 7.91 Million AUD | -670.002% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -20257.901% |
| Biotron Limited | 5.11 Million AUD | -1091.947% |
| Acrux Limited | 8.55 Million AUD | -612.474% |
| Alterity Therapeutics Limited | 23.4 Million AUD | -160.253% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -10022.053% |
| BTC Health Limited | -1.03 Million AUD | 5963.409% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | -208.168% |
| CSL Limited | 7.56 Billion AUD | 99.194% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | -8.186% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | -94.64% |
| Immutep Limited | 42.87 Million AUD | -42.079% |
| Memphasys Limited | 3.67 Million AUD | -1556.069% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | -86.306% |
| Noxopharm Limited | 7 Million AUD | -770.213% |
| Prescient Therapeutics Limited | 10.89 Million AUD | -458.93% |
| Race Oncology Limited | 14.77 Million AUD | -312.421% |
| Starpharma Holdings Limited | 22.81 Million AUD | -166.99% |
| Tissue Repair Ltd | 6.66 Million AUD | -813.728% |
| EZZ Life Science Holdings Limited | 39.57 Million AUD | -53.929% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -8477.173% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -2106.31% |
| Zelira Therapeutics Limited | 5.94 Million AUD | -924.063% |
| Patrys Limited | 4.93 Million AUD | -1134.8% |
| Orthocell Limited | 15.36 Million AUD | -296.346% |
| Imugene Limited | 135.09 Million AUD | 54.907% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -6728.114% |
| Cynata Therapeutics Limited | 11.12 Million AUD | -447.635% |
| Arovella Therapeutics Limited | 10.78 Million AUD | -464.812% |
| Nanollose Limited | 12.5 Thousand AUD | -487193.337% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -1720.642% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -2999.73% |
| Amplia Therapeutics Limited | 8.43 Million AUD | -622.126% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | -1376.637% |
| Nyrada Inc. | 4.55 Million AUD | -1237.306% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 77.377% |
| Dimerix Limited | 25.64 Million AUD | -137.554% |
| PharmAust Limited | 6.65 Million AUD | -815.076% |
| Hexima Limited | 1 Million AUD | -5938.814% |
| AnteoTech Limited | 12.18 Million AUD | -399.848% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | 6.431% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | -180.922% |
| Avecho Biotechnology Limited | 4.54 Million AUD | -1240.182% |
| Actinogen Medical Limited | 22.77 Million AUD | -167.524% |
| Immuron Limited | 9.13 Million AUD | -566.635% |
| Argenica Therapeutics Limited | 8.26 Million AUD | -636.673% |